Follow-The-Filings

Security · featured owners

BIO Bio Rad Labs Inc.

Health Care CL A Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 2.4%
  • $1.1B
  • 2 add 1 reduce 1 exit

BIO (Bio Rad Labs Inc.) is held in 3 featured 13F books as of 2026 Q2. John Rogers - Ariel Investments is the largest tracked holder by portfolio weight (2.4%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 2.4% (John Rogers - Ariel Investments) · not free-float ownership

  1. John Rogers add 2.4%
  2. First Pacific Advisors reduce 1.5%
  3. First Eagle Investment Manage... add 1.3%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
First Eagle Investment Management 2026 Q2 1.3% Add +0.1% 2,606,219 $765M history
John Rogers - Ariel Investments 2026 Q2 2.4% Add +3.9% 816,751 $240M history
First Pacific Advisors 2026 Q2 1.5% Reduce −1.3% 401,861 $118M history
Mason Hawkins - Southeastern Asset Management exited 2026 Q2 last 2026 Q1 2.2% Exit −2.23% 162,804 $45M history

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,2.05,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 7.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 10 rows shown

Filed Form Detail Links
4 Period Sep 4, 2026 · 9 forms Filing Doc
4 Period Sep 1, 2026 · 3 forms Filing Doc
4 Period Jul 25, 2026 Filing Doc
4 Period May 11, 2026 Filing Doc
4 Period Apr 24, 2026 · 2 forms Filing Doc
4 Period Apr 21, 2026 · 4 forms Filing Doc
4 Period Nov 6, 2025 Filing Doc
4 Period Oct 24, 2025 Filing Doc
4 Period Oct 20, 2025 Filing Doc
4 Period Sep 5, 2025 · 2 forms Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.67B $2.57B $2.58B
Gross profit $1.43B $1.38B $1.34B
Gross margin * 53.4% 53.7% 51.9%
Net income -$0.637B -$1.84B $0.76B
Net margin * -23.9% -71.9% 29.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.05B $3.03B $2.91B
Total non-current assets * $9.25B $6.33B $7.67B
Total assets $12.3B $9.36B $10.58B
Total current liabilities $522.8M $467.8M $517M
Total non-current liabilities * $3.04B $2.33B $2.61B
Total equity $8.74B $6.57B $7.45B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $374.94M $455.2M $532.2M
Cash from investing $20.21M -$160.2M -$189.7M
Cash from financing -$425.65M -$218.8M -$283.2M
Net change in cash -$30.18M $85.4M $42.4M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders